DR
Dermata Therapeutics, Inc. Warrant (DRMAW)
NASDAQ·Healthcare·Biotechnology
$0.01
+2.38%
Mkt Cap $11.79K
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$235.75
Range $159.90 – $276.75
Implied Upside
+1827419.4%
Consensus $235.75 vs current $0.01